| 489308 |
AIN SHAMS ENGINEERING JOURNAL |
PMSG driven by wind energy controller based Maxwell-Gaussian optimization technique |
2019-11-01 |
10.1016/j.asej.2019.09.011 |
Mohamed A., Haridy A.L., Senjyu T., Hasanien Hany M., Alkhalaf Salem, Hemeida A.M. |
| 489307 |
BMJ OPEN |
Testing quality indicators and proposing benchmarks for physician-staffed emergency medical services: a prospective Nordic multicentre study |
2019-11-01 |
10.1136/bmjopen-2019-030626 |
Haugland Helge, Olkinuora Anna, Rognås Leif, Ohlen David, Krüger Andreas |
| 489306 |
ONCOTARGETS AND THERAPY |
Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date |
2019-11-01 |
10.2147/ott.s214870 |
Tella Sri Harsha, Mahipal Amit, Kommalapati Anuhya, Jin Zhaohui |
| 489305 |
CANCER MANAGEMENT AND RESEARCH |
Reciprocal Role Of DNA Methylation And Sp1 Binding In Ki-67 Gene Transcription |
2019-11-01 |
10.2147/cmar.s213769 |
Li Lian-Tao, Wang Xun, Zhu Wen-Tao, Qian Guo-Wei, Pei Dong-Sheng, Zheng Jun-Nian |
| 489304 |
ONCOLOGY LETTERS |
Tanshinone IIA reverses EGF‑ and TGF‑β1‑mediated epithelial‑mesenchymal transition in HepG2 cells via the PI3K/Akt/ERK signaling pathway |
2019-11-01 |
10.3892/ol.2019.11032 |
Zhang Longkai, Lin Weibin, Chen Xiaodan, Wei Gang, Zhu Hailong, Xing Shangping |
| 489303 |
NEURO-ONCOLOGY |
IMMU-51. PROFILING THE IMMUNE SYSTEM IN PRIMARY AND RECURRENT GLIOBLASTOMA |
2019-11-01 |
10.1093/neuonc/noz175.543 |
Maddison Kelsey, Graves Moira, Bowden Nikola, Vilain Ricardo, Fay Michael, Tooney Paul |
| 489302 |
NEURO-ONCOLOGY |
ACTR-64. PHASE 2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS AND CLINICAL ACTIVITY OF PI3K/mTOR INHIBITOR GDC-0084 IN GBM PATIENTS WITH UNMETHYLATED O6-METHYLGUANINE-METHYLTRANSFERASE (MGMT) PROMOTER STATUS |
2019-11-01 |
10.1093/neuonc/noz175.106 |
Wen Patrick, DeGroot John, Battiste James, Goldlust Samuel, Garner James, Simpson Jeremy, Kijlstra Jelle, Olivero Alan, Cloughesy Timothy |
| 489301 |
NEURO-ONCOLOGY |
TMIC-08. IDENTIFICATION OF TUMOR SPECIFIC LYMPHOCYTES IN A MURINE GLIOMA MODEL | TMIC-08. IDENTIFICATION OF TUMOR SPECIFIC LYMPHOCYTES IN A MURINE GLIOMA MODEL |
2019-11-01 |
10.1093/neuonc/noz175.1042 |
Shin David, Lamba Nikhil, Flores Catherine, Divita Bayli, Wildes Tyler, Grippin Adam, Fernandez Brandon, Dyson Kyle, Mitchell Duane |
| 489300 |
NEURO-ONCOLOGY |
GENE-49. RNA PROCESSING GENES CHARACTERIZE RNA SPLICING AND FURTHER STRATIFY LOWER-GRADE GLIOMA |
2019-11-01 |
10.1093/neuonc/noz175.451 |
Chai Rui-Chao, jiang tao, Wang Yong-Zhi |
| 489299 |
NEURO-ONCOLOGY |
NIMG-70. A LABEL-FREE APPROACH TO ASSESS CHEMOTHERAPY DRUG CONCENTRATION USING CHEMICAL EXCHANGE SATURATION TRANSFER MRI – A FEASIBILITY STUDY | NIMG-70. A LABEL-FREE APPROACH TO ASSESS CHEMOTHERAPY DRUG CONCENTRATION USING CHEMICAL EXCHANGE SATURATION TR |
2019-11-01 |
10.1093/neuonc/noz175.739 |
Kamson David, Grossman Stuart, Han Zheng, Xu Xiang, van Zijl Peter, Liu Guanshu |
